• potential COVID-19 treatments
• adjuvant therapies
• anticoagulant
• anticoagulant, curative dose
• anticoagulant, pre-admission
• anticoagulant, prophylactic dose
• anticoagulation, intermediate prophylactic dose
• Bivalirudin
• enoxaparin
• heparin at therapeutic dose
• P2Y12 inhibitors
• rivaroxaban
• sulodexide
• face mask
• febuxostat
• hydrogen-oxygen nebulizer
• hyperbaric oxygen
• nintedanib
• paracetamol
• pulmonary rehabilitation
• respiratory support
• anti-inflammatoty and immuno-therapy
• anti-inflammatory therapies
• anti GM-CSF
• mavrilimumab
• Namilumab
• otilimab
• clarithromycine
• colchicine
• Colchicine plus rosuvastatin
• mepolizumab
• naproxen, ibuprofen
• non-steroidal anti-inflammatory drugs
• Celecoxib
• Ibuprofen
• Indomethacin
• selinexor
• sodium aescinate
• stem cells
• tradipitant
• vilobelimab (IFX-1)
• Apilimod
• corticosteroids
• ciclesonide
• dexamethasone
• Dexamethasone 12mg
• dexamethasone 6mg
• Hydrocortisone
• low-dose corticosteroids
• methylprednisolone
• Immunostimulants drugs
• anti-PD-1 antibody
• CD24Fc
• convalescent plasma treatment
• Deferred Convalescent plasma
• Early convalescent plasma.
• immunoglobulin therapy
• inactivated mycobacterium vaccine
• interferon
• IFN beta-1a
• high-dose IFN beta-1a
• IFN beta-1b
• IFN gamma
• inhaled interferon
• IFN alpha
• pegylated interferon-α2b
• recombinant super-compound interferon rSIFN-co
• SNG001 inhaled interferon beta
• interferon / TFF2
• peginterferon
• PNB001
• Interleukin-2
• levamisole
• neutralizing antibody
• amubarvimab/romlusevimab (BRII-196 and BRII-198-Brii Biosciences)
• bamlanivimab monotherapy
• bamlanivimab/etesevimab
• Bebtelovimab (LY-CoV1404)
• bevacizumab
• casirivimab/imdevimab (Ronapreve)
• cilgavimab and tixagevimab (Evusheld)
• equine polyclonal antibodies INM005
• regdanvimab (Regkirona- CT-P59-Celltrion)
• sotrovimab (Xevudy; VIR-7831)
• XAV-19
• rhG-CSF
• Immunosuppressants drugs
• abatacept
• adalimumab
• anakinra
• anti-interleukin-6
• clazakizumab
• Levilimab
• sarilumab
• sarilumab azithromycin hydroxychloroquine
• sarilumab high dose (400mg)
• sarilumab low dose (200mg)
• siltuximab
• tocilizumab
• canakinumab
• cenicriviroc
• complement inhibitors
• conestat alfa
• ravulizumab
• CRAC-channel inhibitors (auxora)
• eculizumab
• emapalumab
• fostamatinib
• infliximab
• itolizumab
• ixekizumab
• jakotinib
• janus kinase (JAK) inhibitor
• baricitinib
• baricitinib plus remdesivir
• ruxolitinib
• TD-0903
• TD-0903 10mg
• TD-0903 1mg
• TD-0903 3mg
• tofacitinib
• lenzilumab
• pamrevlumab
• tacrolimus
• tetrandrine
• thalidomide
• inhaled corticosteroids
• budesonide
• Kinase inhibitors
• acalabrutinib
• imatinib
• leflunomide
• meplazumab
• pirfenidone
• Polyinosinic-Polycytidylic Acid
• sargramostim
• statins
• Atorvastatin
• thymosin
• antiandrogenic
• 5-alpha-reductase inhibitors
• dutasteride
• progesterone
• proxalutamide
• antiviral and associated therapy
• Amantadine
• ASC09/ritonavir
• azithromycin
• azvudine
• baloxavir marboxil
• bromhexine
• carrimycin
• chloroquine and derivatives
• chloroquine
• hydroxychloroquine
• zinc plus hydroxychloroquine
• danoprevir / ritonavir
• darunavir cobicistat
• darunavir/cobicistat plus chloroquine
• doxycycline
• Emtricitabine/tenofovir plus colchicine plus rosuvastatin
• Ensitrelvir (XOCOVA)
• favipiravir
• favipiravir plus interferon
• fluvoxamine
• hydroxychloroquine plus macrolides
• azithromycin plus hydroxychloroquine
• Interferon plus lopinavir/ritonavir
• ivermectin
• ivermectin plus doxycycline
• leronlimab
• lopinavir / ritonavir plus ribavirin
• lopinavir/ritonavir
• lopinavir/ritonavir plus chloroquine
• Lopinavir/ritonavir plus hydroxychloroquine
• lopinavir/ritonavir plus interferon ß-1a
• lopinavir/ritonavir, ribavirin and interferon beta-1b
• molnupiravir
• niclosamide
• nirmatrelvir / ritonavir (Paxlovid)
• nitazoxanide
• opaganib
• oseltamivir
• oseltamivir plus chloroquin
• remdesivir
• ribavirin
• ritonavir
• sofosbuvir
• sofosbuvir and daclatasvir
• sofosbuvir and ledipasvir
• tenofovir/emtricitabine
• tenofovir/emtricitabine plus hydroxychloroquine
• tranexamic acid
• tranilast
• triazavirin
• umifenovir (arbidol)
• zinc
• control
• placebo
• prone positioning
• standard of care
• uncontrolled study
• Drugs for acid related disorders
• bismuth
• H2 blockers
• famotidine
• proton pump inhibitors (PPI)
• miscellaneous
• 2-deoxy-D-glucose (2-DG)
• acetylcysteine
• alpha lipoic acid
• anti-CK2
• Aspirin
• aviptadil
• BLD-2660 (calpain inhibitor)
• calcium channel blocker
• camostat mesilate
• Cannabidiol
• continuous positive airway pressure (CPAP)
• cytokine adsorption
• diammonium glycyrrhizinate
• dipyridamol
• dornase alfa
• expectorants and mucolytics
• honey
• kinin-kallikrein inhibitors
• melatonin
• mouthrise and gargling agents
• mouthrinses
• N-Acetylcysteine
• nasal spray
• nasal spray containing Iota-Carrageenan
• natural killer (NK) cells
• nicotin
• nigella sativa oil
• nitric oxide (gas Inhalation or releasing solution)
• omega-3 Polyunsaturated Fatty Acids
• ozonated autohemotherapy
• plasma exchange
• povidone-iodine
• previfenon (EGCG)
• prostacyclin
• PUL-042 inhalation solution
• pyridostigmine
• radiotherapy
• sabizabulin
• sildenafil
• triiodothyronine (T3)
• Oral antidiabetic drugs
• dapagliflozin
• DPP-4 inhibitor
• metformin
• Renin-angiotensin-system-acting agents
• angiotensin converting enzyme inhibitors (ACEIs)
• angiotensin receptor blockers (ARBs)
• losartan
• angiotensin-(1-7)
• continuation of ACEI/ARB
• discontinuation of ACEI/ARB
• RAS blocker withdrawal
• rhACE2
• vaccines
• A EFFACER BBV152 (Bharat Biotech, India)
• A EFFACER Janssen Ad.26.COV2.S vaccine (JNJ-78436725)
• A EFFACER_ Vero cell
• A EFFACER_sequential Immunization
• BCG vaccination
• complete primary vaccine series
• CoVLP (MT-2766, Medicago)
• DNA vaccine
• bacTRL-Spike
• Zy-Cov-D (Zydus Cadila)
• ebola vaccine
• first booster dose
• mRNA vaccine (any) - first boost
• Comirnaty - first boost
• Spikevax - first boost
• Non replicating viral vector -first boost
• Janssen AD26 vaccine - fisrt boost
• Vaxzevria -first boost
• heterologous prime-boost
• Inactivated virus vaccine
• CoronaVac (SinoVac)
• Covaxin, Bharat Biotech (BBV152)
• Shifa-Pharmed inactivated vaccine
• Sinopharm Beijing (BBIBP-CorV)
• Sinopharm Wuhan
• mRNA vaccine
• Comirnaty (tozinameran - Pfizer/BIONTECH)
• CureVac
• Spikevax (Moderna mRNA-1273 COVID-19 vaccine)
• Non replicating viral vector
• Ad26.RSV.preF (respiratory syncytial virus)
• Ad26.ZEBOV ()
• Ad26.ZIKV.001 (Ad26-Vectored Anti-Zika Virus Vaccine)
• CanSino (Convidecia)
• Covishield (Oxford/AZ formulation)
• Janssen AD26 vaccine (JNJ-78436735)
• Sputnik V (Gam-COVID-Vac)
• SPUTNIK-LIGHT
• Vaxzevria (AstraZeneca Oxford - ChAdOx1 nCoV-19)
• protein subunit vaccine
• Anhui Zhifei Longcom
• CoVax-19 SpikoGen
• Nuvaxovid (NVX-CoV2373) Novavax
• Sanofi/GSK recombinant protein vaccine
• SCB-2019
• Replicating Viral Vector
• seasonal influenza vaccines
• second booster dose
• mRNA vaccine (any) - second boost
• Comirnaty - second boost
• Spikevax - second boost
• virus-like particles vaccine
• Medicago
• Vitamins
• vitamin C
• zinc plus vitamin c
• Vitamin D
• hight dose vitamin D
• RACINE

• vs. potential COVID-19 treatments
• vs. adjuvant therapies
• vs. anticoagulant
• vs. anticoagulant, curative dose
• vs. anticoagulant, prophylactic dose
• vs. antiviral and associated therapy
• vs. chloroquine and derivatives
• vs. hydroxychloroquine
• vs. control
• vs. standard of care

• All
• COVID 19 hospitalized
• COVID 19 all comers
• COVID-19 mild to moderate
• COVID-19 severe or critically
• COVID 19 outpatients
• COVID-19 (hospitalized or not)
• COVID-19 prophylaxis (children)
• COVID-19 prophylaxis (excluding children)
• infections other than COVID-19
• Long COVID-19
• preventing respiratory virus transmission
• root
• secondary prevention